Tuesday, 5 May 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 05 May 2026
News

Sandoz wins consensus on biosims

Posted 5 May 2026 PM

Sandoz says health leaders are united on what needs to be done to increase the uptake of biosimilar medicines in Australia, following the Sandoz Medicines Access and Biosimilar Policy Summit, held in Canberra in March.

“It is clear Australia must better harness the value of biosimilar medicines, which until now has been an unrealised opportunity across the Australian health system,” Sandoz General Manager Australia and New Zealand, Clint Holland, said.

To see the whole article, please login

Popular

Who's made a move to new digs?
Who's won an MA Board seat?
Aussie pharma on the nose
Lilly GM confirms drug launch
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home